News Q32 Bio Inc.

Equities

QTTB

US7469641051

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
25.59 ^USD	-0.70%		-8.67%	+133.83%

Apr. 11	Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target	MT
Apr. 03	Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target	Apr. 11	MT
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer	Apr. 03	PR
Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer	Apr. 03	CI
Piper Sandler Initiates Q32 Bio With Overweight Rating, $45 Price Target	Apr. 02	MT
Q32 Bio Inc.(NasdaqGM:QTTB) added to NASDAQ Composite Index	Mar. 25	CI
Homology Medicines, Inc.(NasdaqGS:FIXX) dropped from NASDAQ Composite Index	Mar. 24	CI
Q32 Bio Inc. announced that it has received $42 million in funding from a group of investors	Mar. 24	CI
Q32 Bio Inc. completed the acquisition of Homology Medicines, Inc. from 5AM Venture Management, LLC, Arch Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P. managed by Arch Venture Partners, L.P., Pfizer Inc. and TLS Beta Pte. Ltd. in a reverse merger transaction.	Mar. 24	CI
North American Morning Briefing : Markets on Hold -2-	Mar. 20	DJ
Homology Medicines Declares Distribution to Common Stockholders	Mar. 18	AQ
Homology Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX	Feb. 27	BU
Neurogene Names Julie Jordan as Chief Medical Officer	Jan. 16	MT
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency	Jan. 03	AQ
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX	Nov. 17	BU
FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders	Nov. 16	BU
Q32 Bio and Homology Medicines Announce Merger Agreement	Nov. 16	PR
Q32 Bio and Homology Medicines Announce Merger Agreement	Nov. 16	AQ
Q32 Bio Inc. announced that it expects to receive $42 million in funding from a group of investors	Nov. 15	CI
Homology Medicines: Q3 Earnings Snapshot	Nov. 14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Q32 Bio Inc.

Equities

QTTB

US7469641051

Summary

Filters